Joseph Wray, MD
Pain Medicine · Loveland, OHNPI 1831582261
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.5%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Boston Scientific at 33.4% of the total. Reporting peaked in 2019 at $9,609 and has fallen 51.4% since, to $4,667 in 2025. Among pain medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 237 payments — averaging $104.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Abbott$5K
- Saluda Medical Americas, Inc.$3K
- Vertos Medical, Inc.$2K
- Nevro Corp.$2K
- Medtronic$2K
- plus $3K from 17 others
What the payments were for
- Grants$6,25025%
- Travel & lodging$5,49422%
- Food & beverage$12,99853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $8,267 |
| Abbott | 49 | $5,332 |
| Saluda Medical Americas, Inc. | 32 | $3,089 |
| Vertos Medical, Inc. | 28 | $1,804 |
| Nevro Corp. | 24 | $1,715 |
| Medtronic(2 entities) | 15 | $1,548 |
| Stryker | 9 | $693 |
| Biotronik NRO, Inc. | 6 | $464 |
| Painteq LLC | 9 | $372 |
| Relievant Medsystems, Inc. | 6 | $360 |
| SPR Therapeutics, Inc | 5 | $162 |
| MML US, Inc. | 2 | $149 |
| Axonics, Inc. | 3 | $131 |
| Spinefrontier, Inc. | 2 | $125 |
| Avanos Medical | 5 | $97 |
| Spinal Simplicity, LLC | 4 | $94 |
| AbbVie | 5 | $92 |
| Curonix LLC | 3 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Merck | 3 | $45 |
| GRT US Holding, Inc. | 2 | $41 |
| Acelrx Pharmaceuticals, Inc. | 1 | $22 |
| Globus Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$7,029
- Evoke$2,693
- PROCLAIM$2,338
- Proclaim Family of SCS IPGs$1,413
- mild Device Kit$1,408
- Senza Spinal Cord Stimulation System$1,088
- INTELLIS$1,086
- Proclaim IPG$425
- Intracept$318
- PAINTEQ$260
- OMNICURVE$149
- CLINICAL TRIAL PRODUCT$144
- Prospera$143
- INTELLIS ADAPTIVESTIM$137
- Senza$136
- ReActiv8$126
- Axonics$107
- InSpan$102
- Sacrix$102
- NanoFuse$102
How this compares
$24,742 in reported general payments places this provider in the 90th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 508 | $14,569 |
| BelbucaBuprenorphine Hcl | 15 | $12,033 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 293 | $6,124 |
| LinzessLinaclotide | 11 | $5,790 |
| Naloxone Hcl | 71 | $4,147 |
| Xtampza ErOxycodone Myristate | 11 | $4,042 |
| Oxycodone Hcl | 139 | $2,919 |
| Pregabalin | 75 | $2,825 |
| Lidocaine | 19 | $2,032 |
| Gabapentin | 156 | $1,913 |
| Tizanidine Hcl | 123 | $1,334 |
| Methocarbamol | 48 | $774 |
| Cyclobenzaprine Hcl | 57 | $600 |
| Tramadol Hcl | 70 | $525 |
| Celecoxib | 33 | $499 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $58 | $16,07526 claims |
| AbbVieLinzess | $92 | $5,79011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 245 pain medicine providers in Ohio.
Other pain medicine in Loveland
- Michael DankoLoveland$381K
- Shruti AminLoveland$10K
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.